四溴-2,5- 环辛基甲基碳酸酯苯 | 145349-66-2

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 羧酸酯及其衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 四溴-2,5- 环辛基甲基碳酸酯苯
• 中文别名: 4-溴-2,5-二氟碘苯；四溴-2,5-环辛基甲基碳酸酯苯
• 英文名称: 1-bromo-2,5-difluoro-4-iodo-benzene
• 英文别名: 4-bromo-2,5-difluoroiodobenzene；1-bromo-2,5-difluoro-4-iodobenzene
• CAS: 145349-66-2
• 化学式: C₆H₂BrF₂I
• 分子量: 318.887
• InChiKey: DOGSQPBKZOMWDT-UHFFFAOYSA-N

物化性质

• 熔点：
  54-57°C
• 沸点：
  236.9±35.0 °C(Predicted)
• 密度：
  2.342±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2903999090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Bromo-2,5-difluoroiodobenzene
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-2,5-difluoroiodobenzene
CAS number: 145349-66-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H2BrF2I
Molecular weight: 318.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  四溴-2,5- 环辛基甲基碳酸酯苯 在 platinum(IV) oxide 正丁基锂 、 氢气 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 生成 1-Bromo-2,5-difluoro-4-pentyl-benzene
  参考文献：
  名称：

  Synthesis, mesomorphic behaviour and optical anisotropy of some novel materials for nematic mixtures of high birefringenceElectronic supplementary information (ESI) available: experimental procedures for all compounds not already given in this paper. See http://www.rsc.org/suppdata/jm/b4/b400630e/

  摘要：

  结构单元包括核心单元（如苯基、萘基和噻吩基）、连接基团（如乙炔基）、末端取代基（如氰基、异硫氰酸基和氟基）以及侧向氟取代基，已被引入到旨在赋予液晶混合物高双折射率的新材料中。这些材料均通过涉及钯催化的芳基硼酸交叉偶联反应的汇聚合成方法制备而成。材料的介晶行为作为纯材料和混合物进行了研究；一些材料被发现具有极高的液晶相稳定性，而另一些则为非介晶性。材料在液晶宿主混合物中被评估其光学各向异性，所有材料均显示出有希望的高值。

  DOI：

  10.1039/b400630e
• 作为产物：
  描述：

  2,5-二氟苯胺 在 盐酸 、 N-溴代丁二酰亚胺(NBS) 、 sodium nitrite 作用下， 以 二氯甲烷 为溶剂， 生成 四溴-2,5- 环辛基甲基碳酸酯苯
  参考文献：
  名称：

  Synthesis, mesomorphic behaviour and optical anisotropy of some novel materials for nematic mixtures of high birefringenceElectronic supplementary information (ESI) available: experimental procedures for all compounds not already given in this paper. See http://www.rsc.org/suppdata/jm/b4/b400630e/

  摘要：

  结构单元包括核心单元（如苯基、萘基和噻吩基）、连接基团（如乙炔基）、末端取代基（如氰基、异硫氰酸基和氟基）以及侧向氟取代基，已被引入到旨在赋予液晶混合物高双折射率的新材料中。这些材料均通过涉及钯催化的芳基硼酸交叉偶联反应的汇聚合成方法制备而成。材料的介晶行为作为纯材料和混合物进行了研究；一些材料被发现具有极高的液晶相稳定性，而另一些则为非介晶性。材料在液晶宿主混合物中被评估其光学各向异性，所有材料均显示出有希望的高值。

  DOI：

  10.1039/b400630e

文献信息

• [EN] CHROMENOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE CHROMÉNOPYRIDINE UTILISÉS EN TANT QU'INHIBITEURS DE LA PHOSPHATIDYLINOSITOL PHOSPHATE KINASE
  申请人：PETRA PHARMA CORP

  公开号：WO2019126730A1

  公开（公告）日：2019-06-27

  The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula (I); where A1, A2, G, R1, R2, R3, R4, and W are described herein.

  这项发明涉及PI5P4K抑制剂，用于治疗癌症、神经退行性疾病、炎症性疾病和代谢性疾病，具有以下式（I）；其中A1、A2、G、R1、R2、R3、R4和W如本文所述。
• [EN] PYRROLE DERIVATIVES AS ACC INHIBITORS<br/>[FR] DÉRIVÉS DE PYRROLE UTILISÉS EN TANT QU'INHIBITEURS D'ACC
  申请人：ALMIRALL SA

  公开号：WO2020245297A1

  公开（公告）日：2020-12-10

  Novel pyrrole derivatives of Formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Acetyl- CoA carboxylase (ACC).

  公式(I)的新吡咯衍生物被公开；以及它们的制备过程、包含它们的药物组合物以及它们作为乙酰辅酶A羧化酶(ACC)抑制剂的疗法应用。
• [EN] ARYL SULTAM DERIVATIVES AS RORc MODULATORS<br/>[FR] DÉRIVÉS D'ARYLE SULTAME UTILISÉS COMME MODULATEURS DE RORC
  申请人：HOFFMANN LA ROCHE

  公开号：WO2017005900A1

  公开（公告）日：2017-01-12

  Compounds of the formula I, or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, X1, X2, X3, X4, Y, Z, A, Het, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein.. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis, muscular sclerosis and psoriasis.

  式I的化合物，或其药学上可接受的盐，其中m、n、p、q、r、X1、X2、X3、X4、Y、Z、A、Het、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12和R13如本文所定义。还公开了制备这些化合物的方法，并将这些化合物用于治疗炎症性疾病，如关节炎、肌肉硬化和牛皮癣。
• Convergent Strategy for the Synthesis of Oxa-, Thia-, and Selena[5]helicenes by Acetylene-Activated S_NAr Reactions
  作者：Samuel M. Hoenig、Youmian Yan、Emily A. Dougherty、Reuben Hudson、Sava Petovic、Christopher K. Lee、Yusheng Hu、Lucas S. Gomez、Jeffrey L. Katz

  DOI：10.1021/acs.joc.0c00052

  日期：2020.3.20

  A tandem acetylene-activated SNAr-anionic cyclization strategy is presented for the synthesis of chalcogen-containing hetero[5]helicenes. Oxa-, thia-, and selena[5]helicenes are accessed from common ortho-fluoro-ethynylarene precursors, allowing the heteroatoms to be installed at the 1-position or 1- and 12-positions of the hetero[5]helicene inner core surface.

  一种串联乙炔活化的小号Ñ氩阴离子环化策略提出了一种含硫属元素的杂[5] helicenes的合成。可从常见的邻氟-乙炔基芳烃前体中获得氧杂，硫杂和硒杂[5]螺旋，使杂原子安装在杂[5]螺旋内芯的1位或1位和12位。表面。
• REDOX MEDIATORS FOR METAL-SULFUR BATTERIES
  申请人：The Regents of the University of California

  公开号：US20170222226A1

  公开（公告）日：2017-08-03

  Metal-sulfur energy storage devices also comprising new redox mediator compounds are described.

  金属硫能量储存装置还包括新的氧化还原中介化合物。